Marksans Pharma Ltd. today raised Rs.372.40 crores through the conversion of warrants into equity shares by OrbiMed Asia IV Mauritius FVCI Limited, and Mr. Mark Saldanha, Promoter of the Company.
Qmed Asia, a Malaysia startup, has launched the Qmed Go mini clinics that include a kiosk that can conduct video consultations and remote patient management in partnership with local general practitioners, according to a press release. The mini clinics, designed…